Affiliation: | (1) Department of Immunology, Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht-Str. 74, 20359 Hamburg, Germany;(2) Leishmaniasis Research Group, Bernhard Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany;(3) Department of Biochemistry and Molecular Biology, University of Hamburg, 20146 Hamburg, Germany;(4) Center for Medical Biotechnology, Fraunhofer Institute for Toxicology and Aerosol Research, 30625 Hannover, Germany;(5) Present address: Division of Biophysics, Forschungszentrum Borstel, Leibniz Center for Medicine and Biosciences, 23845 Borstel, Germany |
Abstract: | To elucidate the role of complement-mediated uptake in Leishmania major infection in vivo, transgenic BALB/c mice that express the cobra venom factor (CVF) under control of the 1-antitrypsin promoter were infected. CVF expression in these mice leads to a continuous activation and subsequent consumption of complement C3 in the serum. In contrast to susceptible non-transgenic BALB/c mice, CVF-transgenic mice are highly resistant to L. major infection and show a significantly reduced parasite dissemination. Transient depletion of C3 in wild-type BALB/c mice delays progression of lesions for some days. Both CVF-transgenic and non-transgenic mice exhibit similar T cell responses upon infection. However, in CVF-transgenic mice, no infiltration of neutrophils, which were the prominent infiltrating cells at the site of infection in normal susceptible mice, could be detected. We conclude that C3 cleavage is required for the attraction of neutrophils that participate in parasite dissemination. |